Synthesis and evaluation of substituted 4-alkoxy-2-aminopyridines as novel neuropeptide Y1 receptor antagonists

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 7, 2004, Pages 1761-1764

  Sato, Nagaaki ^a   Shibata, Takunobu ^a   Jitsuoka, Makoto ^a   Ohno, Toshiyuki ^a   Takahashi, Toshiyuki ^a   Hirohashi, Tomoko ^a   Kanno, Tetsuya ^a   Iwaasa, Hisashi ^a   Kanatani, Akio ^a   Fukami, Takehiro ^a  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPYRIDINE DERIVATIVE; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR;

ARTICLE; DRUG IDENTIFICATION; DRUG SCREENING; DRUG SYNTHESIS; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION;

AMINOPYRIDINES; ANIMALS; CHO CELLS; CRICETINAE; DRUG EVALUATION, PRECLINICAL; HUMANS; RECEPTORS, NEUROPEPTIDE Y;

EID: 12144291459     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.01.049     Document Type: Article

References (18)

1. Tatemoto K., Carlquist M., Mutt V. Nature. 269:1982;659.
2. Clark J.T., Kalra P.S., Crowley W.R., Kalra S.P. Endocrinology. 115:1984;427.
3. Stanley B.G., Leibowitz S.F. Life Sci. 35:1984;2635.
4. Stanley B.G., Kyrkouli S.E., Lampert S., Leibowitz S.F. Peptides. 7:1986;1189.
5. Zarjevski N., Cusin I., Vettor R., Rohner-Jeanrenaud F., Jeanrenaud B. Endocrinology. 133:1993;1753.
6. Erickson J.C., Hollopeter G., Palmiter R.D. Science. 274:1996;1704.
7. Gerald C., Walker M.W., Criscione L., Gustafson E.L., Batzl-Hartmann C., Smith K.E., Vaysse P., Durkin M.M., Laz T.M., Linemeyer D.L., Schaffhauser A.O., Whitebread S., Hofbauer K.G., Taber R.I., Branchek T.A., Weinshank R.L. Nature. 382:1996;168.
8. Marsh D.J., Hollopeter G., Kafer K.E., Palmiter R.D. Nat. Med. 4:1998;718.
9. Petruzzelli R., Barra D., Bossa F., Condo S.G., Brix O., Nuutinen M., Giardina B. Biochim. Biophys. Acta. Protein Struct. Mol. Enzymol. 1076:1991;221.
10. Inui A. Trends Pharmacol. Sci. 20:1999;43.
11. Kanatani A., Mashiko S., Murai N., Sugimoto N., Ito J., Fukuroda T., Fukami T., Morin N., MacNeil D.J., Van der Ploeg L.H.T., Saga Y., Nishimura S., Ihara M. Endocrinology. 41:2000;1011.
12. Kanatani A., Kanno T., Ishihara A., Hata M., Sakuraba A., Tanaka T., Tsuchiya Y., Mase T., Fukuroda T., Fukami T., Ihara M. Biochem. Biophys. Res. Commun. 266:1999;88.
13. Kanatani A., Hata M., Mashiko S., Ishihara A., Okamoto O., Haga Y., Ohe T., Kanno T., Murai N., Ishii Y., Fukuroda T., Fukami T., Ihara M. Mol. Pharmcol. 59:2001;501.
14. Fukami, T.; Mase, T.; Tsuchiya, Y.; Kanatani, A.; Fukuroda, T. PCT WO 97/34873.
15. Niiyama K., Nagase T., Fukami T., Takezawa Y., Takezawa H., Hioki Y., Takeshita H., Ishikawa K. Bioorg. Med. Chem. Lett. 7:1997;527.
16. See ref 13 for the experimental conditions for the binding and functional assays described herein.
17. 3CN-TFA 95:5:0.1 to 5:95:0.1 over 6 min and at a flow rate of 0.8 mL/min.
18. +.